Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
about
Suppressive Effects of Tea Catechins on Breast CancerNew insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallateCancer Preventive Activities of Tea CatechinsLong-term vitamin E supplementation reduces atherosclerosis and mortality in Ldlr-/- mice, but not when fed Western style diet.Cancer prevention by tea: animal studies, molecular mechanisms and human relevance.Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer.Epigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion.Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer.(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.Tea and human health: biomedical functions of tea active components and current issuesAnti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapyProtective effects of green tea against prostate cancer.Oat Attenuation of Hyperglycemia-Induced Retinal Oxidative Stress and NF-κB Activation in Streptozotocin-Induced Diabetic RatsPrognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer.Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.Tea beverage in chemoprevention and chemotherapy of prostate cancer.Back to basics: how natural products can provide the basis for new therapeutics.Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells.Mitogenesis of vascular smooth muscle cell stimulated by platelet-derived growth factor-bb is inhibited by blocking of intracellular signaling by epigallocatechin-3-O-gallate.Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCGPreparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.Green tea and cancer prevention.Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.Mechanistic issues concerning cancer prevention by tea catechins.Multifunctional T Lymphocytes Generated After Therapy With an Antitumor Gallotanin-Rich Normalized Fraction Are Related to Primary Tumor Size Reduction in a Breast Cancer Model.Polyphenols in Health and Disease.Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.Effects of Tea Catechins on Cancer Signaling Pathways.Methylated-(3'')-epigallocatechin gallate analog suppresses tumor growth in Huh7 hepatoma cells via inhibition of angiogenesis.HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium.The modulation of endothelial cell gene expression by green tea polyphenol-EGCG.Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation.The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation.ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein.Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis.Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics.
P2860
Q26739963-149A6761-0C79-42F1-9FCA-A4064FDAB8FFQ27012831-D72B5426-F53F-41AB-BA93-449601DE2627Q28076334-2208647C-C3BF-4011-B8D1-E1EE3DFEEBC8Q33637932-F7844DBC-305F-42F6-ADB5-3FDDCAF282DEQ33693371-BDE80924-A0E6-41BE-B130-AC5C83200357Q34068169-5CD7C554-28EC-48C3-BDFD-FC404269D185Q34099507-D566CA3A-41F0-4E15-94DF-225C9D8369B1Q34381481-589649BD-6D85-4896-A772-79DF29C8D044Q34616966-704FADCD-B62A-4FC0-AF33-168A54035E18Q34733112-BE3F5B60-2CA2-4693-9D3C-F90C8021539EQ34993694-65D980C9-6A34-406B-985A-6701F8A74F46Q35065939-3A82D780-F754-4429-8B96-9C485BAA7317Q35834584-51E15175-5711-4094-8C95-D4BDA95E27F4Q36448671-87ACA785-844B-40FC-98E9-A0E7AA6E8DB0Q36566092-1B6DF07D-EC75-4FE2-BB4F-C4215F56B77BQ36611459-38BF2CC5-EA85-43F9-A76E-E6D52AA5D88AQ36876370-8321F9E4-7802-4E53-AAB6-D3FEE7423834Q36920776-1677D5D7-505E-42F5-9F8D-79F1CF09DE8EQ36985862-096D7700-57E3-4474-B18D-B7CA2C032F38Q37294809-4557A9DE-DCD7-4B15-8D54-445FC8A7FAE3Q37331993-10A714D1-99F8-4085-BB3B-CF96E92B0E08Q37424846-5771B767-3412-474A-8F57-8478AF5FF82BQ37573788-11A5A8F0-F008-46DF-AF9E-27524522ABCAQ37798221-6BB989F8-BFC3-4455-8FA0-716E36B21BDBQ37871559-E364B408-767A-4E63-8644-6A2AD5BCA3C4Q37871562-7263BB38-2165-4ADB-B9F8-A3E61F1C8C15Q38848418-C6FF69DC-DE88-4179-A5A7-2A019AB4E3C4Q38853155-57BE9DFB-120E-4C8A-81CE-8733DF3BA5E1Q38950984-951926C3-E992-4A75-AF79-A9D26A0B12CFQ39039219-D1C9A5E4-6C9B-4067-9C16-180ED9894E9CQ39096443-1F703090-B450-4679-86F2-5775AC0418D4Q39599360-3E383B49-BF95-4918-A465-C99A75239837Q41769428-AC495E62-792E-46FA-9AFD-E58DF7B849DEQ46852214-B5E7FB5A-4D9B-49B9-A2F6-FB5AEC3909F2Q48160662-6B5E2942-E9E9-458E-A790-2FF42BD3848EQ48577940-47329DDB-5AEE-4ADA-A713-E6625AF05892Q50472228-53AC813A-E7B4-41E3-A626-15F277A3A839Q54190983-3385A919-9DC0-46B7-8D0B-AF5029700D51
P2860
Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Green tea catechin, epigalloca ...... rmation of a receptor complex.
@ast
Green tea catechin, epigalloca ...... rmation of a receptor complex.
@en
Green tea catechin, epigalloca ...... rmation of a receptor complex.
@nl
type
label
Green tea catechin, epigalloca ...... rmation of a receptor complex.
@ast
Green tea catechin, epigalloca ...... rmation of a receptor complex.
@en
Green tea catechin, epigalloca ...... rmation of a receptor complex.
@nl
prefLabel
Green tea catechin, epigalloca ...... rmation of a receptor complex.
@ast
Green tea catechin, epigalloca ...... rmation of a receptor complex.
@en
Green tea catechin, epigalloca ...... rmation of a receptor complex.
@nl
P2093
P2860
P356
P1476
Green tea catechin, epigalloca ...... ormation of a receptor complex
@en
P2093
Eric K Paulson
Liping Liu
Michael A Band
Mohsen Meydani
Shaun K Rodriguez
P2860
P304
P356
10.1002/IJC.21545
P50
P577
2006-04-01T00:00:00Z